{"title": "Open-science model for drug discovery expands to neurodegenerative diseases", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/pharmaceuticals.xml", "value": "Open-science model for drug discovery expands to neurodegenerative diseases"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2019/02/190215162034.htm"}], "link": "https://www.sciencedaily.com/releases/2019/02/190215162034.htm", "summary": "Parkinson's disease and Amyotrophic Lateral Sclerosis are the newest frontiers for open science drug discovery, a global movement led by academic scientists that puts knowledge sharing and medication affordability ahead of patents and profits.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/pharmaceuticals.xml", "value": "Parkinson's disease and Amyotrophic Lateral Sclerosis are the newest frontiers for open science drug discovery, a global movement led by academic scientists that puts knowledge sharing and medication affordability ahead of patents and profits."}, "published": "Fri, 15 Feb 2019 16:20:34 EST", "published_parsed": [2019, 2, 15, 21, 20, 34, 4, 46, 0], "id": "https://www.sciencedaily.com/releases/2019/02/190215162034.htm", "guidislink": false}